These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9346372)

  • 1. Immunointervention based on Th2-type cytokines in HIV infection.
    Galanaud P; Fior R; Boue F; Emilie D
    Eur Cytokine Netw; 1997 Sep; 8(3):315-6. PubMed ID: 9346372
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy for HIV Infection.
    Weiss RA
    N Engl J Med; 2014 Jan; 370(4):379-80. PubMed ID: 24450898
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS pathogenesis: mathematical models of HIV and SIV infections.
    Nowak M; May RM
    AIDS; 1993; 7 Suppl 1():S3-18. PubMed ID: 8363800
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 5. Containing HIV after infection.
    Walker BD; Rosenberg ES
    Nat Med; 2000 Oct; 6(10):1094-5. PubMed ID: 11017132
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS vaccine models: challenging challenge viruses.
    Feinberg MB; Moore JP
    Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
    [No Abstract]   [Full Text] [Related]  

  • 7. An Occam's razor approach to the immunopathogenesis of HIV infection.
    Clerici M; Shearer GM
    AIDS; 1995; 9 Suppl A():S33-40. PubMed ID: 8819567
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
    Shimizu Y; Miyazaki Y; Ibuki K; Suzuki H; Kaneyasu K; Goto Y; Hayami M; Miura T; Haga T
    Virology; 2005 Dec; 343(2):151-61. PubMed ID: 16169034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL responses to HIV and SIV: wrestling with smoke.
    John M; Mallal S
    Nat Immunol; 2005 Mar; 6(3):232-4. PubMed ID: 15716970
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interleukins and HIV disease].
    Galanaud P; Emilie D
    C R Seances Soc Biol Fil; 1994; 188(1):23-30. PubMed ID: 7994626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and simian immunodeficiency virus infections.
    Rosenberg YJ; Lewis MG; Villinger F; Ansari AA
    Res Immunol; 1994; 145(8-9):706-12; discussion 712-3. PubMed ID: 7754224
    [No Abstract]   [Full Text] [Related]  

  • 12. A need for clear animal data--"and the animal might have to be man". An interview with Robert L. Coffman, PhD. Interview by Mark Mascolini.
    Coffman RL
    J Int Assoc Physicians AIDS Care; 1995 May; 1(4):23-4. PubMed ID: 11362506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral burden in AIDS.
    Dalgleish AG
    Nature; 1993 Nov; 366(6450):22. PubMed ID: 8232531
    [No Abstract]   [Full Text] [Related]  

  • 15. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
    Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM
    Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in RANTES gene expression and T-cell prevalence in intestinal mucosa during pathogenic or nonpathogenic simian immunodeficiency virus infection.
    Ndolo T; Rheinhardt J; Zaragoza M; Smit-McBride Z; Dandekar S
    Virology; 1999 Jun; 259(1):110-8. PubMed ID: 10364494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is an HIV vaccine possible?
    McMichael AJ; Hanke T
    Nat Med; 1999 Jun; 5(6):612-4. PubMed ID: 10371492
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory and enhancing effects of IFN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection.
    Buch S; Pinson D; King CL; Raghavan R; Hou Y; Li Z; Adany I; Hicks A; Villinger F; Kumar A; Narayan O
    Cytokine; 2001 Mar; 13(5):295-304. PubMed ID: 11243708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium and interleukins in persons infected with human immunodeficiency virus type 1.
    Baum MK; Miguez-Burbano MJ; Campa A; Shor-Posner G
    J Infect Dis; 2000 Sep; 182 Suppl 1():S69-73. PubMed ID: 10944486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.